31
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Targeting QseC signaling and virulence for antibiotic development.

      Science (New York, N.Y.)
      Animals, Anti-Bacterial Agents, administration & dosage, pharmacology, therapeutic use, Enterohemorrhagic Escherichia coli, drug effects, genetics, metabolism, pathogenicity, Escherichia coli Infections, drug therapy, Escherichia coli Proteins, antagonists & inhibitors, Francisella tularensis, Gene Expression Regulation, Bacterial, Gram-Negative Bacterial Infections, Mice, Norepinephrine, Phosphorylation, Protein Kinases, Rabbits, Salmonella Infections, Animal, Salmonella typhimurium, Signal Transduction, Small Molecule Libraries, Sulfonamides, chemistry, Tularemia, Virulence Factors

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Many bacterial pathogens rely on a conserved membrane histidine sensor kinase, QseC, to respond to host adrenergic signaling molecules and bacterial signals in order to promote the expression of virulence factors. Using a high-throughput screen, we identified a small molecule, LED209, that inhibits the binding of signals to QseC, preventing its autophosphorylation and consequently inhibiting QseC-mediated activation of virulence gene expression. LED209 is not toxic and does not inhibit pathogen growth; however, this compound markedly inhibits the virulence of several pathogens in vitro and in vivo in animals. Inhibition of signaling offers a strategy for the development of broad-spectrum antimicrobial drugs.

          Related collections

          Author and article information

          Comments

          Comment on this article